Programs
​

Calder applies its di-tyrosine conformational locking approach to render feasible, for the first time, the production of vaccines that protect against key viral diseases that represent both significant unmet medical needs and blockbuster commercial opportunities. These are a vaccine against Respiratory Syncytial Virus (RSV), a common pediatric infection and a universal Influenza.

Both immunogens are conformationally stabilized with DT crosslinks and studies are now underway in collaboration with opinion leaders to test them.